Genmark Diagnostics (GNMK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 40,572 | 44,360 | 36,286 | 26,754 | 15,959 |
| Marketable Securities | 87,582 | 9,100 | 8,882 | 45,236 | 25,607 |
| Receivables | 20,790 | 16,759 | 11,534 | 10,676 | 9,048 |
| Inventories | 21,323 | 11,301 | 10,244 | 10,949 | 6,633 |
| Other current assets | 2,695 | 1,877 | 0 | 0 | 0 |
| TOTAL | $172,962 | $83,397 | $68,429 | $95,831 | $58,449 |
| Non-Current Assets | |||||
| PPE Net | 38,362 | 20,419 | 21,070 | 22,581 | 18,268 |
| Intangibles | 841 | 1,432 | 2,023 | 2,624 | 2,670 |
| Other Non-Current Assets | 11,369 | 6,225 | 1,459 | 1,263 | 937 |
| TOTAL | $50,572 | $28,076 | $24,552 | $26,468 | $21,875 |
| Total Assets | $223,534 | $111,473 | $92,981 | $122,299 | $80,324 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 7,927 | 7,935 |
| Accounts payable and accrued liabilities | 23,071 | 12,249 | 9,886 | 11,171 | 8,703 |
| Accrued Expenses | 12,716 | 7,493 | 7,358 | 5,419 | 5,650 |
| Other current liabilities | 5,250 | 2,732 | 3,043 | 3,226 | 4,133 |
| TOTAL | $44,130 | $24,316 | $20,287 | $27,743 | $26,421 |
| Non-Current Liabilities | |||||
| Long Term Debt | 71,297 | 69,145 | 36,042 | 20,099 | 11,880 |
| Other Non-Current Liabilities | 13,909 | 5,849 | 109 | 241 | 220 |
| TOTAL | $85,206 | $74,994 | $39,147 | $23,399 | $15,752 |
| Total Liabilities | $129,336 | $99,310 | $59,434 | $51,142 | $42,173 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 73,086 | 60,776 | 56,472 | 55,167 | 47,051 |
| Common Shares | 7 | 6 | 6 | 6 | 4 |
| Retained earnings | -532,877 | -514,233 | -466,883 | -416,383 | -355,270 |
| Other shareholders' equity | 252 | 96 | 80 | 9 | 95 |
| TOTAL | $94,198 | $12,163 | $33,547 | $71,157 | $38,151 |
| Total Liabilities And Equity | $223,534 | $111,473 | $92,981 | $122,299 | $80,324 |